What is JBIO's net income?

JBIO (JBIO) reported net income of -$40.37M in Q1 2026.

How has JBIO's net income changed year-over-year?

JBIO's net income decreased by 5.8% year-over-year, from -$38.17M to -$40.37M.

What is the long-term trend for JBIO's net income?

Over 4 years (2021 to 2025), JBIO's net income has grown at a 53.5% compound annual growth rate (CAGR), from -$22.96M to -$127.41M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

JBIO JBIO Net Income

Net Income at other companies

Vertex PharmaceuticalsVRTX

$1.03B+59.6%

Travere Therapeutics, Inc.TVTX

-$37.1M+10.0%

Vera TherapeuticsVERA

-$121.03M-134%

AnaptysBio, Inc.ANAB

-$52.88M-34.5%

Cullinan Therapeutics, Inc.CGEM

-$49.66M-2.4%

Viridian Therapeutics, Inc.VRDN

-$104.9M-20.7%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B—

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's net income?: JBIO (JBIO) reported net income of -$40.37M in Q1 2026.
How has JBIO's net income changed year-over-year?: JBIO's net income decreased by 5.8% year-over-year, from -$38.17M to -$40.37M.
What is the long-term trend for JBIO's net income?: Over 4 years (2021 to 2025), JBIO's net income has grown at a 53.5% compound annual growth rate (CAGR), from -$22.96M to -$127.41M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.